LIGACHEM BIOSCIENCES INC.

Press Releases LigaChem Biosciences Inc.

Equities

A141080

KR7141080002

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
65,700 ^KRW	-1.20%		-3.95%	+1.08%

08/04	NextCure, Inc. and LigaChem Biosciences, Inc. Present Preclinical Data on B7-H4 Antibody Drug Conjugate At AACR 2024	CI
29/03	Pan Orion Corp. Ltd. completed the acquisition of 4.93% stake in LegoChem Biosciences, Inc. from Kim Yong Ju and Park Se Jin.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	08/02	AQ
LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial	08/11	AQ
LegoChem Biosciences : WuXi XDC and LegoChem Biosciences sign Memorandum of Understanding	10/21/10	AQ
Legochem Biosciences : CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate	29/20/29	AQ
LegoChem Biosciences : and Takeda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates in Immuno-Oncology	22/19/22	BU
LegoChem Biosciences : Receives US Patent for Its Own Proprietary ADC Platform Technology ConjuAllTM	17/17/17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW